Padma Kumar Narayanan

Amgen (United States)

Papers

1

Total Citations

15

H-Index

1

About

Padma Kumar Narayanan is a pioneering figure in the field of high-throughput drug screening and single-cell analysis. His research focuses on developing automated systems that bridge the gap between bulk assays and the nuanced behaviors of individual cells, enabling precise, real-time functional readouts. His landmark 2013 work, "High-Throughput Secondary Screening at the Single-Cell Level," introduced a semiautomated platform integrating high-speed sample collection with instantaneous analytical tools for compound dilutions in 384-well formats. This innovation allows researchers to capture multiple functional responses from single cells simultaneously, dramatically accelerating the identification of promising drug candidates. With 15 citations, this paper has laid critical groundwork for precision pharmacology and toxicology. Narayanan’s contributions are particularly notable for their emphasis on scalability and automation, making single-cell analysis practical for industrial and academic screening pipelines. His work empowers researchers to move beyond population averages, revealing rare cellular responses that are often missed in conventional assays. For students and scientists exploring the frontiers of personalized medicine or drug discovery, Narayanan’s systems represent a transformative tool for interrogating cellular heterogeneity with unprecedented speed and resolution.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Secondary Screening at the Single-Cell Level
15 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago